Aurobindo Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 10, 2025
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has issued the formal notice for its 38th Annual General Meeting, scheduled for Wednesday, September 10, 2025, at 3:30 p.m. IST via Video Conferencing (VC). Shareholders will consider adoption of audited standalone and consolidated financial statements for FY25 (year ended March 31, 2025). Two directors — Mr. P. Sarath Chandra Reddy and Dr. Satakarni Makkapati — are seeking re-appointment, as they retire by rotation. A special business item proposes appointing M/s. MRR & Associates as Secretarial Auditor for a five-year term covering FY26 through FY30. The e-voting window runs from September 7 to September 9, 2025, with September 3, 2025 set as the record/cut-off date. The Register of Members will be closed from September 8 to September 10, 2025.
This is a routine AGM notice with no major corporate actions like dividends, fundraising, or M&A. Shareholders holding shares as of September 3, 2025 are eligible to vote electronically on the proposed resolutions. The stock price is unlikely to react materially unless new material information is disclosed during the meeting.